SUPN: Supernus, Inc.
Performance
SUPN +13.58%
Watchlist
Select an item
Summary
SUPN at a glance
SUPN returned +13.58% over the past year. Its worst drop in that year was -22.42%, smaller than 75% of stocks on Redstone, and its Sharpe ratio of 0.44 beats 47% of stocks on Redstone. It pays no dividends.
Current Drawdown
-14.90%
Rolling Volatility
40.60%
Actions
Metrics
Risk Indicators
Alpha7.54%
Beta0.73x
Sharpe0.44
Sortino0.67
Omega1.08
Calmar0.61
Martin1.39
Profile
About SUPN
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.6B
- Listed
- May 2012
- Employees
- 778
- Headquarters
- North Chesterfield, VA
- Website
- supernus.com
Comparisons